![C. Jillian Tsai: CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN](https://oncodaily.com/pub/uploads/2024/02/download-43-e1708614734210.jpg)
Photo taken from C. Jillian Tsai/X
Feb 22, 2024, 11:12
C. Jillian Tsai: CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN
C. Jillian Tsai, Radiation Oncologist at Princess Margaret Cancer Centre, Toronto, Canada, shared a post on X/Twitter:
“CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN. (F/u of Ph2 CURB RCT The Lancet”
Source: C. Jillian Tsai/X